DBVT Q4 2022 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

-$1M-144.5% YoY

Gross Profit

-$1M100.0% margin

Operating Income

-$38M2915.4% margin

Net Income

-$39M3009.3% margin

EPS (Diluted)

$-2.10

QoQ Revenue Growth

-Infinity%

Cash Flow

Operating Cash Flow

-$24M

Free Cash Flow

-$24M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$247M

Total Liabilities

$52M

Stockholders' Equity

$194M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	-$1M	$3M	-144.5%
Gross Profit	-$1M	$3M	-144.5%
Operating Income	-$38M	-$13M	-182.1%
Net Income	-$39M	-$14M	-187.0%